The HeartRhythm app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Now available for both iPad and iPhone!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Minimum requirements: IOS 8
Journal subscribers: Log in with the same username and password that grants you access to the full journal content on HeartRhythm website. These credentials will allow full access to all content on the app.
HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community.
iTunes Subscriptions to HeartRhythm
A single issue of the journal for $31.99
1-year subscription to the journal for $199.99
Payment for all purchases will be charged to your iTunes account upon confirmation of purchase.
iTunes Subscriber’s Auto-Renew Feature
Yearly iTunes subscriptions will automatically renew each year unless you cancel. You can cancel at any time and up to 24 hours before your current subscription expires. Your iTunes account will automatically be charged the same price for the renewal within 24 hours prior to the end of the current period unless you change your subscription preferences in your iTunes Account Settings. You can manage your subscriptions through your Account Settings after purchase. No cancellation of the current subscription is allowed during the active subscription period.
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Watch video highlights from the BeCOn OWN 2017 event, including expert opinion, patient experience and panel discussions in the Breakthrough Cancer Pain Learning Zone.
Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.
View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more.
Quality of life (QOL) is an important outcome in spinal cord injury (SCI) rehabilitation, but it is unclear how to define and measure it.
Added 9 months ago
Lysosomal storage disorders represent a group of at least 41 genetically distinct, biochemically related, inherited diseases.
Added 7 months ago
Effectiveness and tolerability of injectable testosterone undecanoate: a post-marketing surveillance study
This observational post-marketing study of parenteral testosterone undecanoate (TU) in a non-selected population.
Added 4 months ago
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men.
In 2014, the International Society for Sexual Medicine (ISSM) convened a panel of experts to develop an evidence-based process of care for the diagnosis and management of testosterone deficiency (TD) in adult men.
Added 10 months ago
Despite increased global interest in testosterone deficiency in men and its treatment with testosterone therapy, practical aspects of care remain confusing to many practitioners.
Added 10 months ago
Test your cruciverbalist credentials with our healthcare themed crossword!
Added 2 months ago
EU approves Votubia (everolimus) as adjunctive treatment for partial-onset seizures associated with tuberous sclerosis complex- Novartis
Novartis announced that the European Commission has approved Votubia (everolimus) dispersible tablets as an adjunctive treatment for patients aged two...
Added 1 year ago
CHMP recommends Votubia (everolimus) to treat partial-onset seizures, with or without secondary generalization associated with tuberous sclerosis complex.- Novartis
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...
Added 1 year ago
Epidiolex (cannabidiol or CBD) commences Phase III study to treat tuberous sclerosis complex- GW Pharma
GW Pharmaceuticals has commenced a Phase III clinical trial of Epidiolex (cannabidiol or CBD) as an adjunctive therapy for the...
Added 1 year ago
This week has been 'Urology Week 2017'.
Added 5 months ago
To assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.
Added 2 years ago
Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
The study evaluated the efficacy and safety of letermovir (MK-8228) for the prevention of clinically-significant CMV infection in adult, CMV-seropositive recipients of allogeneic hematopoietic stem cell transplant (HSCT).
Added 1 month ago
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
To investigate safety, tolerability, PK and PD of BI 655075 and to establish the BI 655075 dose(s) effective to reverse...
Added 5 years ago
Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
The purpose of this observer-blind study is to gather key efficacy, safety, and immunogenicity information on GSK's candidate malaria vaccine...
Added 10 years ago
Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants (HAVEN 5)
This randomized, multicenter, open-label, Phase 3 study is designed to investigate the efficacy, safety, and pharmacokinetics of emicizumab in participants with hemophilia A regardless of factor VIII (FVIII) inhibitor status.
Added 15 days ago
The objective is to formulate clinical practice guidelines for treating Cushing's syndrome.
Added 6 months ago
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Mortality rates ranging between 2% and 21% have...
Added 5 years ago
This guideline will therefore provide advice and rationale for health professionals in making choices and decisions in the management of this disease.
Added 4 days ago
Venous thromboembolism (VTE) and bleeding are serious complications of cancer and its treatment. A recent survey of UK paediatric haematologists and oncologists identified a broad variety of practice in the management of issues...
Added 5 days ago